Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v3-EN
Language French English
Date Updated 2018-05-11 2017-04-16
Drug Identification Number 00608165 00608165
Brand name RATIO-OXYCOCET RATIO-OXYCOCET
Common or Proper name 500 500
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ACETAMINOPHEN OXYCODONE HYDROCHLORIDE ACETAMINOPHEN OXYCODONE HYDROCHLORIDE
Strength(s) 325MG 5MG 325MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 500
ATC code N02AJ N02AJ
ATC description
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2017-04-15
Actual start date 2017-06-01
Estimated end date 2018-04-30 2017-06-30
Actual end date 2018-04-30
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Partial releases throughout recovery period
Health Canada comments